The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kinsella Kevin J since 2006.
The trader's CIK number is 1311643.
At the time of the last reporting, Kinsella Kevin J was the Director of Akesis Pharmaceuticals, Inc.. (stock ticker symbol AKES.OB).
Also see all insider trading activities at Akesis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | AKES.OB | 2,352,942 | $2,000,000 | 0 | $0 | 0 | $0 |
| 2007 | AKES.OB | 317,500 | $164,962 | 0 | $0 | 0 | $0 |
| 2006 | AKES.OB | 5,000,000 | $3,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-25 | AKES.OB | Buy | 2,352,942 | .85 | 2,000,000 |
| 2007-11-19 | AKES.OB | Buy | 20,000 | .72 | 14,500 |
| 2007-09-12 | AKES.OB | Buy | 15,000 | .56 | 8,445 |
| 2007-09-13 | AKES.OB | Buy | 7,500 | .66 | 4,950 |
| 2007-09-11 | AKES.OB | Buy | 12,500 | .52 | 6,437 |
| 2007-09-10 | AKES.OB | Buy | 25,000 | .53 | 13,200 |
| 2007-09-06 | AKES.OB | Buy | 20,000 | .48 | 9,540 |
| 2007-09-04 | AKES.OB | Buy | 15,000 | .47 | 7,050 |
| 2007-09-05 | AKES.OB | Buy | 20,000 | .47 | 9,500 |
| 2007-08-30 | AKES.OB | Buy | 15,000 | .49 | 7,350 |
| 2007-08-31 | AKES.OB | Buy | 17,500 | .50 | 8,750 |
| 2007-08-28 | AKES.OB | Buy | 5,000 | .47 | 2,350 |
| 2007-08-29 | AKES.OB | Buy | 10,000 | .48 | 4,800 |
| 2007-08-24 | AKES.OB | Buy | 5,000 | .51 | 2,550 |
| 2007-08-22 | AKES.OB | Buy | 10,000 | .51 | 5,050 |
| 2007-08-23 | AKES.OB | Buy | 15,000 | .50 | 7,500 |
| 2007-08-21 | AKES.OB | Buy | 55,000 | .53 | 29,315 |
| 2007-08-20 | AKES.OB | Buy | 10,000 | .51 | 5,050 |
| 2007-08-16 | AKES.OB | Buy | 35,000 | .47 | 16,275 |
| 2007-08-17 | AKES.OB | Buy | 5,000 | .47 | 2,350 |
| 2006-11-21 | AKES.OB | Buy | 5,000,000 | .60 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kinsella Kevin J (Director of Akesis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.